Skip to main content
. 2015 Dec 2;10(12):e0143894. doi: 10.1371/journal.pone.0143894

Table 2. Associations between miRNA expression and SNPs in miRNA genes and miRNA-target genes by genotype in non-tumor tissue (adjusted for age, sex and center).

AA AB BB p-values
Gene(s) SNP miRNA N Mean % 0 Exp N Mean % 0 Exp N Mean % 0 Exp Raw FDR Variant Type 3
miRNA
CD22, MIR5196 rs10406069, 0 = GG 1 = GA 2 = AA hsa-miR-5196-5p 218 64.14 0.00 105 60.93 0.00 21 61.38 0.00 0.029 0.52 IN, DS, MS, 3' UTR, of CD22. NC, NCE of MIR5196.
MCM7, MIR106B, MIR25, MIR93 rs1527423, 0 = AA 1 = AG 2 = GG hsa-miR-25-3p 86 14.51 9.30 182 12.40 10.44 76 10.41 21.05 0.004 0.49 DS of COPS6. IN, NC, DS, NMD of MCM7. UP of MIR106B, MIR25, MIR93.
GNN, HSP90B1, MIR3652 rs17797090, 0 = GG 1 = GA 2 = AA hsa-miR-3652 288 159.68 0.00 56 145.86 0.00 0 NA NA 0.032 0.52 RR. TFB, 5' UTR, NMD, NC, NCE, IN of HSP90B1. NCE, NC of MIR3652. UP of RP11-642P15.
MIR146A rs2910164, 0 = GG 1 = GC 2 = CC hsa-miR-146a-5p 197 8.24 32.49 129 8.29 31.01 18 6.61 5.56 0.038 0.52 NC, NCE.
MIR1307, USMG5 rs7911488, 0 = AA 1 = AG 2 = GG hsa-miR-1307-3p 154 13.03 0.00 153 13.03 0.65 37 11.27 0.00 0.019 0.52 NC, NCE of MIR1307. UP of PDCD11. IN, 5' UTR of USMG5.
RPL17, RPL17-C18orf32, SNORD58A, SNORD58 rs1943676, 0 = AA 1 = AG 2 = GG hsa-miR-1539 147 4.24 36.73 167 4.10 53.89 30 4.02 56.67 0.004 0.49 RR. UP of C18orf32. IN, NC, DS of MIR1539. SP, IN, NC, NCE, UP of RPL17. UP, DS of SNORD58A, SNORD58B, SNORD58C. DS of SRP72P1.
miRNA-Target
NRSN1 rs1053047, 0 = GG 1 = GA 2 = AA hsa-miR-143-5p 92 3.96 94.57 175 3.39 92.57 77 5.36 84.42 0.029 0.52 3' UTR, DS, IN.
KIAA0423 (FAM179B)* rs1053667, 0 = TT 1 = TC 2 = CC hsa-miR-19b-3p 305 11.19 14.10 39 13.44 28.21 0 NA NA 0.028 0.52 DS, 3' UTR, NMD.
SLC10A7 rs1057560, 0 = GG 1 = GA 2 = AA hsa-miR-25-3p 97 11.54 14.43 171 12.39 13.45 76 14.09 7.89 0.039 0.52 RR. 3' UTR, DS.
DNM2 rs12232826, 0 = GG 1 = GT 2 = TT hsa-miR-638 314 3980.05 0.00 30 4412.26 0.00 0 NA NA 0.013 0.52 IN.
CSK rs1378940, 0 = AA 1 = AC 2 = CC hsa-miR-4513 159 27.91 0.00 139 30.08 0.00 46 30.68 0.00 0.027 0.52 RR. UP, IN, NC.
hsa-miR-1207-5p 212 2043.96 0.00 117 1911.72 0.00 15 1699.90 0.00 0.016 0.52
ICOS rs1559931, 0 = GG 1 = GA 2 = AA hsa-miR-196b-5p 212 9.00 24.53 117 8.24 16.24 15 6.35 0.00 0.037 0.52 RR. 3' UTR.
hsa-miR-2117 212 4.53 50.47 117 4.61 46.15 15 4.74 20.00 0.033 0.52
LAD1 rs16848494, 0 = CC 1 = CT 2 = TT hsa-miR-143-5p 328 4.28 90.85 16 0.00 100.00 0 NA NA 0.027 0.52 DS, 3' UTR, IN of LAD1. UP of TNNT2.
AFF1 rs17703261, 0 = AA 1 = AT 2 = TT hsa-miR-648 211 18.23 0.00 121 17.48 0.00 12 14.98 0.00 0.022 0.52 3' UTR, DS.
hsa-miR-1207-5p 212 2043.96 0.00 117 1911.72 0.00 15 1699.90 0.00 0.020 0.52
ICOS rs4404254, 0 = TT 1 = TC 2 = CC hsa-miR-196b-5p 212 9.00 24.53 117 8.24 16.24 15 6.35 0.00 0.034 0.52 3' UTR.
hsa-miR-2117 212 4.53 50.47 117 4.61 46.15 15 4.74 20.00 0.035 0.52
NKAIN4, FLJ16779 rs720607, 0 = GG 1 = GA 2 = AA hsa-miR-3196 112 1415.24 0.00 163 1326.52 0.00 69 1269.88 0.00 0.027 0.52 RR. IN.
CD80 rs7628626, 0 = CC 1 = CA 2 = AA hsa-miR-2117 233 4.67 42.06 98 4.40 62.24 13 3.69 38.46 0.010 0.52 RR. DS, 3' UTR, of CD80. DS of TIMMDC1.
FGF2 rs7683093, 0 = CC 1 = CG 2 = GG hsa-miR-92b-3p 249 1.34 93.17 84 2.01 82.14 11 0.73 81.82 0.008 0.52 RR. DS, 3' UTR of FGF2. IN, NMD, DS, US of NUDT6.
BRCA1 rs8176318, 0 = CC 1 = CA 2 = AA hsa-miR-525-5p 165 3.20 46.67 130 3.16 51.54 49 3.85 69.39 0.035 0.52 3' UTR, DS.
PARP1 rs8679, 0 = AA 1 = AG 2 = GG hsa-miR-630 212 364.38 0.00 106 392.44 0.00 26 541.85 0.00 0.013 0.52 3' UTR, DS.
SELS (VIMP)* rs9874, 0 = TT 1 = TC 2 = CC hsa-miR-181a-5p 268 25.24 0.00 69 29.71 0.00 7 25.02 0.00 0.027 0.52 3' UTR, DS.
MCM7, AP4M1 rs999885, 0 = AA 1 = AG 2 = GG hsa-miR-25-3p 88 14.45 9.09 180 12.36 10.00 76 10.51 22.37 0.003 0.49 IN, NMD, UP, NC, DS of AP4M1. UP of MCM7. DS of TAF6.

1Related SNPs are those in linkage disequilibrium to SNPs within the dataset.

2EX: Exon; DS: Downstream; IN: intron; MS: Missense; NC: Non-coding; NCE: Non-coding exon; NMD: Nonsense-mediated decay; RR: Regulatory region; SN: Synonymous; SPR: Splice Region; TFB: Transcription Factor Binding site; US: Upstream.

3Variant Analysis was performed with Ensembl's VEP (GRCh37.p13). Multiple type of variants are listed for a given gene when these variant occur in different transcripts.

4This SNP has now merged into a new SNP (GRCh38).

5For miRNA Gene Regions this column has the miRNA with the SNP; for miRNA-target genes this column has the associated miRNA for the mRNA with the SNP.

6Association seen in literature.

*Names in parentheses are alternatives.